Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Strategies for labeling proteins with PARACEST agents.

Vasalatiy O, Zhao P, Woods M, Marconescu A, Castillo-Muzquiz A, Thorpe P, Kiefer GE, Sherry AD.

Bioorg Med Chem. 2011 Feb 1;19(3):1106-14. doi: 10.1016/j.bmc.2010.06.026. Epub 2010 Jun 18.

2.

Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.

Ali MM, Yoo B, Pagel MD.

Mol Pharm. 2009 Sep-Oct;6(5):1409-16. doi: 10.1021/mp900040u.

3.

Polymeric PARACEST agents for enhancing MRI contrast sensitivity.

Wu Y, Zhou Y, Ouari O, Woods M, Zhao P, Soesbe TC, Kiefer GE, Sherry AD.

J Am Chem Soc. 2008 Oct 22;130(42):13854-5. doi: 10.1021/ja805775u. Epub 2008 Sep 26.

4.

A sensitive PARACEST contrast agent for temperature MRI: Eu3+-DOTAM-glycine (Gly)-phenylalanine (Phe).

Li AX, Wojciechowski F, Suchy M, Jones CK, Hudson RH, Menon RS, Bartha R.

Magn Reson Med. 2008 Feb;59(2):374-81. doi: 10.1002/mrm.21482.

5.
6.

Dendritic PARACEST contrast agents for magnetic resonance imaging.

Pikkemaat JA, Wegh RT, Lamerichs R, van de Molengraaf RA, Langereis S, Burdinski D, Raymond AY, Janssen HM, de Waal BF, Willard NP, Meijer EW, Grüll H.

Contrast Media Mol Imaging. 2007 Sep-Oct;2(5):229-39.

PMID:
17937448
7.

Albumin-binding PARACEST agents.

Ali MM, Woods M, Suh EH, Kovacs Z, Tircsó G, Zhao P, Kodibagkar VD, Sherry AD.

J Biol Inorg Chem. 2007 Aug;12(6):855-65. Epub 2007 May 30.

8.

Engineering lanthanide complexes with controlled water exchange rates for magnetic resonance imaging.

Woods M, Sherry AD.

Conf Proc IEEE Eng Med Biol Soc. 2004;7:5254-7.

PMID:
17271525
9.

Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.

Winter PM, Cai K, Chen J, Adair CR, Kiefer GE, Athey PS, Gaffney PJ, Buff CE, Robertson JD, Caruthers SD, Wickline SA, Lanza GM.

Magn Reson Med. 2006 Dec;56(6):1384-8.

10.

MRI thermometry based on PARACEST agents.

Zhang S, Malloy CR, Sherry AD.

J Am Chem Soc. 2005 Dec 21;127(50):17572-3.

11.

Fine-tuning water exchange on Gd(III) poly(amino carboxylates) by modulation of steric crowding.

Jászberényi Z, Sour A, Tóth E, Benmelouka M, Merbach AE.

Dalton Trans. 2005 Aug 21;(16):2713-9. Epub 2005 Jul 12.

PMID:
16075110
12.

Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI.

Woessner DE, Zhang S, Merritt ME, Sherry AD.

Magn Reson Med. 2005 Apr;53(4):790-9.

13.

New insights for pursuing high relaxivity MRI agents from modelling the binding interaction of Gd(III) chelates to HSA.

Aime S, Gianolio E, Longo D, Pagliarin R, Lovazzano C, Sisti M.

Chembiochem. 2005 May;6(5):818-20. No abstract available.

PMID:
15791689
14.
15.

Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.

Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, Hockett F, Robertson JD, Gaffney PJ, Lanza GM, Wickline SA.

Magn Reson Med. 2004 Dec;52(6):1255-62.

17.

Lanthanide(III) complexes of novel mixed carboxylic-phosphorus acid derivatives of diethylenetriamine: a step towards more efficient MRI contrast agents.

Kotek J, Lebdusková P, Hermann P, Vander Elst L, Muller RN, Geraldes CF, Maschmeyer T, Lukes I, Peters JA.

Chemistry. 2003 Dec 5;9(23):5899-915.

PMID:
14673862
18.

Supramolecular adducts between poly-L-arginine and [TmIIIdotp]: a route to sensitivity-enhanced magnetic resonance imaging-chemical exchange saturation transfer agents.

Aime S, Delli Castelli D, Terreno E.

Angew Chem Int Ed Engl. 2003 Sep 29;42(37):4527-9. No abstract available.

PMID:
14520757
19.
20.

Improved molecular imaging contrast agent for detection of human thrombus.

Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM.

Magn Reson Med. 2003 Aug;50(2):411-6.

Supplemental Content

Support Center